“Our call strategies did not yield the desired outcomes, and we recognized the need for additional data to better support our goal. We were also mindful of the potential risk of staff burnout and the impact it could have on overall performance.” —Carey Lawrence, Revenue Cycle Administrator Customer Service and Self-Pay Collections, Weill Cornell Medicine…
Roche is buying 89bio to get pegozafermin, a drug currently in two Phase 3 studies for the fatty liver disease MASH. Beyond the $2.4 billion payable when the deal closes, another $1.1 billion in contingent value right payments is tied to the achievement of commercial milestones for the projected blockbuster seller. The post Roche’s Metabolic…
Democratic state attorneys general led by those from California, New York, and Massachusetts are pressuring medical professional groups to defend reproductive rights, including medication abortion, emergency abortions, and travel between states for health care in response to recent increases in the number of abortion bans. The American Medical Association adopted a formal position June 9…
Novo Nordisk is acquiring Akero Therapeutics for drug candidate efruxifermin, which executive say could be first and best in the emerging class of FGF21 analogs for the fatty liver disease MASH. The deal comes months after Novo’s internal FGF21 drug candidate failed a Phase 2 trial. The post With $4.7B Akero Acquisition, Novo Nordisk Maps…
No revolutionary naval vessels, fighter planes, or weapon systems were involved. Rather, this one was about staffing military healthcare facilities. Make no mistake, though: It’s also revolutionary. The post A Revolution in Military Medical Staffing is Afoot and Private Sector Firms are Playing a Big Part appeared first on MedCity News.
El gobierno de Trump presentó un amplio paquete de propuestas regulatorias que cambiarían de manera sustancial la oferta de planes de salud en los mercados establecidos por la Ley de Cuidado de Salud a Bajo Precio (ACA) el próximo año. Según el gobierno, el objetivo es ofrecer más opciones y primas más bajas. Sin embargo,…
We need to embrace a more holistic, integrated approach to mental healthcare: one that combines the best of human expertise with rapid innovations of technology, all while being mindful of the real-world challenges faced by marginalized and underserved communities. The post Reimagining Mental Healthcare: We Need A New Road, Not A Bigger Truck appeared first…
Under the Medicare Drug Price Negotiation Program, the federal government negotiates prices with drug companies for certain high-cost drugs covered under Medicare Part B and Part D. This brief provides information about several key aspects of the Medicare drug price negotiation program, with a focus on the 2028 implementation year.
NASHVILLE, Tenn. — Federal prosecutors sought a maximum prison sentence of nearly 20 years for the CEO of Pain MD, a company found to have given hundreds of thousands of questionable injections to patients, many reliant on opioids. It would have been among the longest sentences for a health care executive convicted of fraud in…
In this month’s episode, Senior Reporter Katie Adams discussed some of the executive moves, exits and layoffs that recently occurred in the healthcare world. She also interviewed Amy Abernethy, who recently co-founded Highlander Health with fellow healthcare veteran Brad Hirsch. The post MedCity Moves Podcast: Recent Hires, Layoffs & an Interview with Amy Abernethy, Co-Founder…